Creatine as nutritional supplementation and medicinal product.

肌酸 磷酸肌酸 一水肌酸 医学 肌酸激酶 药代动力学 药理学 内科学 能量代谢 安慰剂 病理 替代医学
作者
G. Benzi,Angelo Ceci
出处
期刊:PubMed 卷期号:41 (1): 1-10 被引量:40
链接
标识
摘要

Because of assumed ergogenic effects, the creatine administration has become popular practice among subjects participating in different sports. Appropriate creatine monohydrate dosage may be considered a medicinal product since, in accordance with the Council Directive 65/65/EEC, any substance which may be administered with a view to restoring, correcting or modifying physiological functions in humans beings is considered a medicinal product. Thus, quality, efficacy and safety must characterise the substance. In addition, the European Court of Justice has held that a product which is recommended or described as having preventive or curative properties is a medicinal product even if it is generally considered as a foodstuff and even if it has no known therapeutic effect in the present state of scientific knowledge. In biochemical terms, creatine administration increases creatine and phosphocreatine muscle concentration, allowing for an accelerated rate of ATP synthesis. In thermodynamics terms, creatine stimulates the creatine-creatine kinase-phosphocreatine circuit, which is related to the mitochondrial function as a highly organised system for the control of the subcellular adenylate pool. In pharmacokinetics terms, creatine entry into skeletal muscle is initially dependent on the extracellular concentration, but the creatine transport is subsequently downregulated. In pharmacodynamics terms, the creatine enhances the possibility to maintain power output during brief periods of high-intensity exercises. In spite of uncontrolled daily dosage and long-term administration, no researches on creatine monohydrate safety in humans were set up by standardised protocols of clinical pharmacology and toxicology, as currently occurs in phases I and II for products for human use. More or less documented side effects induced by creatine monohydrate are weight gain; influence on insulin production; feedback inhibition of endogenous creatine synthesis; long-term damages on renal function. A major point that related to the quality of creatine monohydrate products is the amount of creatine ingested in relation to the amount of contaminants present. During the industrial production of creatine monohydrate from sarcosine and cyanamide, variable amounts of contaminants (dicyandiamide, dihydrotriazines, creatinine, ions) are generated and, thus, their tolerable concentrations (ppm) must be defined and made consumers known. Furthermore, because sarcosine could originate from bovine tissues, the risk of contamination with prion of bovine spongiform encephalopathy (BSE or mad-cow disease) can t be excluded. Thus, French authorities forbade the sale of products containing creatine. Creatine, as other nutritional factors, can be used either at supplementary or therapeutic levels as a function of the dose. Supplementary doses of nutritional factors usually are of the order of the daily turnover, while therapeutic ones are three or more times higher. In a subject of 70 kg with a total creatine pool of 120 g, the daily turnover is approximately of 2 g. Thus, in healthy subjects nourished with fat-rich, carbohydrate, protein-poor diet and participating in a daily recreational sport, the oral creatine monohydrate supplementation should be of the order of the daily turnover, i.e., less than 2.5-3 g per day, bringing the gastrointestinal absorption to account. In healthy athletes submitted daily to high-intensity strength or sprint training, the maximal oral creatine monohydrate supplementation should be of the order of two times the daily turnover, i.e., less than 5-6 g per day for less than two weeks, and the creatine monohydrate supplementation should be taken under appropriate medical supervision. The oral administration of more that 6 g per day of creatine monohydrate should be considered as a therapeutic intervention and should be prescribed by physicians only in the cases of suspected or proven deficiency, or in conditions of severe stress and/or injury. The incorporation of creatine into the medicinal product class is supported also by the use in pathological conditions, e.g., some mitochondrial cytopathies, the guanidinoacetate methyltransferase deficiency, etc.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
huangyao发布了新的文献求助10
2秒前
2秒前
大个应助乐观的颦采纳,获得200
2秒前
慕青应助AlvinCZY采纳,获得10
4秒前
Flicker完成签到 ,获得积分10
5秒前
诸葛语琴发布了新的文献求助10
5秒前
7秒前
wlz发布了新的文献求助10
8秒前
诸葛语琴完成签到,获得积分10
10秒前
万能图书馆应助早发论文采纳,获得10
11秒前
小梦完成签到,获得积分10
12秒前
18秒前
jj发布了新的文献求助10
21秒前
guandada完成签到,获得积分10
22秒前
23秒前
爆米花应助虚幻的电灯胆采纳,获得10
25秒前
25秒前
25秒前
guandada发布了新的文献求助30
27秒前
29秒前
tanzhouliang发布了新的文献求助10
30秒前
祁代芙发布了新的文献求助20
30秒前
完美世界应助jj采纳,获得30
32秒前
传奇3应助tanzhouliang采纳,获得10
38秒前
40秒前
李健应助科研通管家采纳,获得10
41秒前
41秒前
打打应助科研通管家采纳,获得10
41秒前
薰硝壤应助科研通管家采纳,获得30
41秒前
41秒前
Mutsu应助科研通管家采纳,获得20
41秒前
科研通AI2S应助科研通管家采纳,获得30
41秒前
Jasper应助科研通管家采纳,获得10
41秒前
41秒前
sine_mora发布了新的文献求助10
43秒前
悦耳非笑发布了新的文献求助30
44秒前
FXe完成签到,获得积分10
51秒前
我是老大应助KoitoYuu采纳,获得10
52秒前
pcr163应助杨茉采纳,获得60
55秒前
高分求助中
The ACS Guide to Scholarly Communication 2500
Sustainability in Tides Chemistry 2000
Pharmacogenomics: Applications to Patient Care, Third Edition 1000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 810
《粉体与多孔固体材料的吸附原理、方法及应用》(需要中文翻译版,化学工业出版社,陈建,周力,王奋英等译) 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3084205
求助须知:如何正确求助?哪些是违规求助? 2737236
关于积分的说明 7544249
捐赠科研通 2386802
什么是DOI,文献DOI怎么找? 1265552
科研通“疑难数据库(出版商)”最低求助积分说明 613127
版权声明 598187